Developer docs
API playgroundTry for free, no card

Search company profiles

Endpoint

Full company profile

uuid003dpaa

Namestring
Endpoint
Legal namestring
Endpoint ApS
Websiteurl
endpoint.dk
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Endpoint ApS is a small, privately held Danish strategic advisory consultancy specializing in healthcare Market Access and Public Affairs. Founded and headquartered in Copenhagen at Flæsketorvet 28 in the Kødbyen district, the firm operates from a shared office environment (NOHO) and serves pharmaceutical companies, medical technology firms, and public healthcare organizations operating in Denmark. The company is registered as an Anpartsselskab (ApS) under Danish company law with CVR number 42525227, is a member of DI (Dansk Industri / Confederation of Danish Industry), and is led by Managing Director and partner Sarah Fredberg with support from associated consultant Hans Villendrup and finance lead Peter Hartmann — a team of approximately three professionals leveraging more than 30 years of combined pharmaceutical industry experience.

Endpoint's offering is structured around two integrated service lines: Public Affairs and Market Access. The Public Affairs practice provides strategic advisory on healthcare politics, political messaging qualification, stakeholder engagement spanning the Danish Parliament to municipal councils, and planning of hearings, conferences and events. The Market Access practice helps clients identify and break down barriers to market entry, maps stakeholders, develops strategies to optimize commercial potential for pharmaceutical and medical technology products, and delivers tailored Market Access training courses. There is no proprietary technology platform, software product, or digital tool underlying the offering — the firm's value proposition rests entirely on advisor expertise, sector relationships, and tailored engagement deliverables delivered via on-site meetings, online meetings, or at the Copenhagen office.

The business operates as a classic boutique professional services firm on a sales-led, direct engagement model. Services are sold through personalized outreach and initial non-committal consultation conversations, with pricing quoted on a per-engagement basis rather than through publicly disclosed rate cards. Revenue derives from project-based advisory work and potentially retainer arrangements with pharmaceutical, medtech, and public sector clients. The firm maintains a limited public footprint — a LinkedIn company page (Endpoint DK) is the primary digital channel — and the geographic scope is explicitly domestic Denmark, with no evidence of cross-border delivery or international expansion.

Short descriptiontext

Endpoint ApS is a small Danish healthcare consultancy offering strategic advisory in Market Access and Public Affairs to pharmaceutical companies, medtech firms, and public healthcare organizations across Denmark, leveraging 30-plus years of combined pharmaceutical industry experience.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHolme-olstrup, Denmark
HQ citystring
Holme-olstrup
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare consulting, market access advisory, public affairs consulting, pharmaceutical strategy, healthcare stakeholder engagement
NAICS code1 code
  • Other Management Consulting Services541618
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Healthcare Consulting Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Strategic Advisory Services
TypeProfessional Services
Description

Professional consulting services including Market Access advisory, Public Affairs consulting, and training courses. Revenue appears to be generated through project-based engagements and potentially retainer arrangements with clients in the pharmaceutical and healthcare sectors.

endpoint.dk
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Endpoint provides strategic advisory services within the Danish healthcare sector, with two integrated service lines: Public Affairs (political engagement, stakeholder communication, and public-private collaboration) and Market Access (identifying and breaking down barriers for successful market entry of pharmaceutical and medical technology products). Services are delivered through direct client consultations, training courses, and stakeholder engagement.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Endpoint is a strategic healthcare consulting firm offering two integrated service lines: Public Affairs (political engagement and stakeholder communication) and Market Access (barrier identification and commercial optimization for pharmaceutical and medical technology products). The company leverages over 30 years of collective experience in the pharmaceutical industry and maintains a broad network of politicians, civil servants, patient organizations, and healthcare personnel.

Product and service2 records
1Public Affairs
CategoryHealthcare Consulting
Description

Strategic advisory service within healthcare politics, helping clients understand and participate in political processes, qualify healthcare political messaging, and engage with stakeholders from the Danish Parliament to town councils. Services include strategic advisory, public-private collaboration, and planning of hearings, audiences, conferences and events. Targeted at pharmaceutical and medtech companies and public healthcare organizations in Denmark.

2Market Access
CategoryHealthcare Consulting
Description

Strategic advisory service helping clients identify, understand and break down barriers for successful market access of pharmaceutical and medical technology products in Denmark. Includes mapping stakeholders, developing strategies to optimize commercial potential, and providing Market Access courses tailored to client needs.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

A global healthcare communications and consulting organization offering medical communications, market access, and creative services. A larger, broader competitor with capabilities that overlap Endpoint's full service stack.

TypeBroad incumbent
Description

A larger UK-based healthcare communications group with capabilities spanning medical communications, market access, and public affairs. Broader portfolio than Endpoint but operates in overlapping service categories.

3Hanover Communications
TypeDirect peer
Description

European healthcare public affairs and communications consultancy with a strong health policy practice. Comparable to Endpoint's Public Affairs service line for pharma and medtech clients navigating complex regulatory environments.

TypeDirect peer
Description

North American market access and commercial strategy consultancy serving pharma and medtech clients. Directly comparable on market access advisory offerings for healthcare product launches.

TypeBroad incumbent
Description

A large contract research organization and commercial services provider with a dedicated consulting practice covering market access and public affairs for pharma and medtech. A scaled incumbent in the same advisory space.

TypeDirect peer
Description

A UK-based consultancy dedicated to pharmaceutical market access, providing strategy, health economics, and stakeholder engagement support. Highly comparable to Endpoint's Market Access service line, though operating in a different European geography.

TypeBroad incumbent
Description

US-based health policy, market access, and strategic consulting firm serving life sciences companies. Comparable on health policy and market access advisory, though with a US rather than European/Danish focus.

TypeDirect peer
Description

A specialized healthcare communications and marketing agency serving pharma clients. Overlaps with Endpoint on strategic advisory for healthcare product launches, though more weighted toward marketing communications.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Endpoint

Healthcare Consulting Servicesendpoint.dk

Endpoint ApS is a small Danish healthcare consultancy offering strategic advisory in Market Access and Public Affairs to pharmaceutical companies, medtech firms, and public healthcare organizations across Denmark, leveraging 30-plus years of combined pharmaceutical industry experience.

What Endpoint does

Endpoint ApS is a small, privately held Danish strategic advisory consultancy specializing in healthcare Market Access and Public Affairs. Founded and headquartered in Copenhagen at Flæsketorvet 28 in the Kødbyen district, the firm operates from a shared office environment (NOHO) and serves pharmaceutical companies, medical technology firms, and public healthcare organizations operating in Denmark. The company is registered as an Anpartsselskab (ApS) under Danish company law with CVR number 42525227, is a member of DI (Dansk Industri / Confederation of Danish Industry), and is led by Managing Director and partner Sarah Fredberg with support from associated consultant Hans Villendrup and finance lead Peter Hartmann — a team of approximately three professionals leveraging more than 30 years of combined pharmaceutical industry experience.

Endpoint's offering is structured around two integrated service lines: Public Affairs and Market Access. The Public Affairs practice provides strategic advisory on healthcare politics, political messaging qualification, stakeholder engagement spanning the Danish Parliament to municipal councils, and planning of hearings, conferences and events. The Market Access practice helps clients identify and break down barriers to market entry, maps stakeholders, develops strategies to optimize commercial potential for pharmaceutical and medical technology products, and delivers tailored Market Access training courses. There is no proprietary technology platform, software product, or digital tool underlying the offering — the firm's value proposition rests entirely on advisor expertise, sector relationships, and tailored engagement deliverables delivered via on-site meetings, online meetings, or at the Copenhagen office.

The business operates as a classic boutique professional services firm on a sales-led, direct engagement model. Services are sold through personalized outreach and initial non-committal consultation conversations, with pricing quoted on a per-engagement basis rather than through publicly disclosed rate cards. Revenue derives from project-based advisory work and potentially retainer arrangements with pharmaceutical, medtech, and public sector clients. The firm maintains a limited public footprint — a LinkedIn company page (Endpoint DK) is the primary digital channel — and the geographic scope is explicitly domestic Denmark, with no evidence of cross-border delivery or international expansion.

Endpoint firmographics

Firmographics
Name
Endpoint
Legal name
Endpoint ApS
Website
https://endpoint.dk
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Endpoint ApS is a small Danish healthcare consultancy offering strategic advisory in Market Access and Public Affairs to pharmaceutical companies, medtech firms, and public healthcare organizations across Denmark, leveraging 30-plus years of combined pharmaceutical industry experience.
Ownership category
akta.pro rank

Where Endpoint is headquartered

Location

Headquarters

HQ city
Holme-olstrup
HQ country
Denmark
HQ region
Europe

Offices1 record

Markets served

Endpoint business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Revenue model

  1. Strategic Advisory Services: Professional consulting services including Market Access advisory, Public Affairs consulting, and training courses. Revenue appears to be generated through project-based engagements and potentially retainer arrangements with clients in the pharmaceutical and healthcare sectors.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Endpoint product offering

Product offering

Core offering

Endpoint provides strategic advisory services within the Danish healthcare sector, with two integrated service lines: Public Affairs (political engagement, stakeholder communication, and public-private collaboration) and Market Access (identifying and breaking down barriers for successful market entry of pharmaceutical and medical technology products). Services are delivered through direct client consultations, training courses, and stakeholder engagement.

Product overview

Endpoint is a strategic healthcare consulting firm offering two integrated service lines: Public Affairs (political engagement and stakeholder communication) and Market Access (barrier identification and commercial optimization for pharmaceutical and medical technology products). The company leverages over 30 years of collective experience in the pharmaceutical industry and maintains a broad network of politicians, civil servants, patient organizations, and healthcare personnel.

Differentiator

Problem solved

Functional benefit

Products and services

  • Public Affairs Strategic advisory service within healthcare politics, helping clients understand and participate in political processes, qualify healthcare political messaging, and engage with stakeholders from the Danish Parliament to town councils. Services include strategic advisory, public-private collaboration, and planning of hearings, audiences, conferences and events. Targeted at pharmaceutical and medtech companies and public healthcare organizations in Denmark.
  • Market Access Strategic advisory service helping clients identify, understand and break down barriers for successful market access of pharmaceutical and medical technology products in Denmark. Includes mapping stakeholders, developing strategies to optimize commercial potential, and providing Market Access courses tailored to client needs.

Companies that use Endpoint

Customer profile

Segments3 records

Ideal customer profiles3 records

Endpoint technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Endpoint partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Endpoint competitors and assessment

Company assessment

Broad incumbents

  • Fishawack Health: A global healthcare communications and consulting organization offering medical communications, market access, and creative services. A larger, broader competitor with capabilities that overlap Endpoint's full service stack.
  • Lucid Group: A larger UK-based healthcare communications group with capabilities spanning medical communications, market access, and public affairs. Broader portfolio than Endpoint but operates in overlapping service categories.
  • Syneos Health Consulting: A large contract research organization and commercial services provider with a dedicated consulting practice covering market access and public affairs for pharma and medtech. A scaled incumbent in the same advisory space.
  • Avalere Health: US-based health policy, market access, and strategic consulting firm serving life sciences companies. Comparable on health policy and market access advisory, though with a US rather than European/Danish focus.

Direct peers

  • Hanover Communications: European healthcare public affairs and communications consultancy with a strong health policy practice. Comparable to Endpoint's Public Affairs service line for pharma and medtech clients navigating complex regulatory environments.
  • AESARA: North American market access and commercial strategy consultancy serving pharma and medtech clients. Directly comparable on market access advisory offerings for healthcare product launches.
  • MAP BioPharma: A UK-based consultancy dedicated to pharmaceutical market access, providing strategy, health economics, and stakeholder engagement support. Highly comparable to Endpoint's Market Access service line, though operating in a different European geography.
  • COUCH Health: A specialized healthcare communications and marketing agency serving pharma clients. Overlaps with Endpoint on strategic advisory for healthcare product launches, though more weighted toward marketing communications.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Endpoint social profiles

Digital presence

Endpoint financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Endpoint leadership team

Management profile

Number of profiles

Profiles3 records

Endpoint funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Endpoint M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Endpoint

What does Endpoint do?

Endpoint provides strategic advisory services within the Danish healthcare sector, with two integrated service lines: Public Affairs (political engagement, stakeholder communication, and public-private collaboration) and Market Access (identifying and breaking down barriers for successful market entry of pharmaceutical and medical technology products). Services are delivered through direct client consultations, training courses, and stakeholder engagement.

Is Endpoint a public or private company?

Endpoint is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Endpoint founded?

Endpoint was founded in -1. It employs 1 to 10 people.

Where is Endpoint based?

Endpoint is headquartered in Holme-olstrup, Denmark, in the Europe region.

How does Endpoint make money?

One revenue line is on record: strategic Advisory Services.

Who are Endpoint's main competitors?

Broad incumbents on record are Fishawack Health, Lucid Group, Syneos Health Consulting and Avalere Health. Direct peers are Hanover Communications, AESARA, MAP BioPharma and COUCH Health.

Does Endpoint have an API?

No public API is recorded for Endpoint.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales